株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

動物用ワクチンの世界市場の分析

Animal Pharm Veterinary Vaccines 2018

発行 Animal Pharm 商品コード 338394
出版日 ページ情報 英文 133 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=107.36円で換算しております。
Back to Top
動物用ワクチンの世界市場の分析 Animal Pharm Veterinary Vaccines 2018
出版日: 2018年09月01日 ページ情報: 英文 133 Pages
概要

ワクチンは、アニマルヘルス市場で革新的な成長を続けています。特に、豚・家禽用ワクチン部門で著しい進展を遂げています。

当レポートでは、世界の動物用ワクチン市場について調査分析し、現在の状況、技術と動向、市場と企業、規制について、体系的な情報を提供しています。

第1章 動物用ワクチンと世界の畜産

  • イントロダクション
  • ワクチン

第2章 世界市場と企業

  • アニマルヘルス市場
  • アニマルヘルス企業
  • 地域例

第3章 ワクチン開発と生産

  • ワクチンへの反応
  • 細菌感染への免疫反応
  • ウイルス感染への免疫反応
  • 寄生虫感染への免疫反応
  • 粘膜免疫

第4章 ワクチン技術

  • 従来型ワクチン
  • ワクチン開発への分子アプローチ
  • ワクチン安定性における現在の問題

第5章 アジュバント・その他のキャリア使用で免疫反応を増強

  • アジュバントとは
  • アジュバントへの新興アプローチ
  • 注入部位反応
  • アジュバントデリバリーシステム
  • 免疫増強物質としてのサイトカイン
  • ナノ粒子
  • その他の潜在的アジュバント
  • レーザーアジュバント

第6章 家禽用ワクチン

第7章 牛・小型反芻動物 (羊・ヤギ) 用ワクチン

  • 子牛の腸疾患
  • 牛の呼吸器疾患 (BRD)
  • 牛の生殖器系ワクチン
  • 牛結核
  • 乳房炎ワクチン
  • ダニワクチン
  • その他の寄生虫ワクチン
  • 羊・ヤギ用ワクチン

第8章 豚用ワクチン

  • 腸疾患
  • ウイルス性ワクチン

第9章 コンパニオンアニマル (ペット) 用ワクチン

  • 犬用ワクチン
  • 猫用ワクチン
  • 馬用ワクチン

第10章 水産用ワクチン

  • イントロダクション
  • 魚用自家ワクチン
  • 水産用ウイルス性ワクチン
  • 水産用細菌ワクチン
  • 魚用ワクチン投与
  • 魚用ワクチンの新興デリバリーシステム

第11章 ワクチンの投与経路

  • 無針のワクチン接種
  • 経口/粘膜経路
  • 魚用ワクチンの経口投与

第12章 動物用ワクチンの国際規制

第13章 将来の見通し

目次
Product Code: 89408

Vaccines continue to lead the animal health market in terms of innovative growth. There has been significant progress in the pig and poultry vaccine sectors in particular. Aquaculture has also seen a substantial risedue to the emergence of novel infectious diseases that require innovative solutions.

This report presents a detailed overview of the role of vaccines in the animal health market.

Key Insights include:

  • Current Status
  • Technologies and Trends
  • Markets and Companies
  • Regulations

Table of Contents

Contents

Executive Summary

Chapter 1: Veterinary vaccines and the global animal industries

  • 1.1. Introduction
  • 1.2. Where do vaccines fit?

Chapter 2: Global markets and companies

  • 2.1. The animal health market
  • 2.2. The animal health companies
  • 2.3. Examples of territories
    • 2.3.1. Asia
    • 2.3.2. China
    • 2.3.3. Latin America
    • 2.3.4. Middle East Region
    • 2.3.5. Saudi Arabia

Chapter 3: Vaccine development and production

  • 3.1. The response to vaccination
  • 3.2. Immune response to bacterial infection
  • 3.3. Immune response to viral infection
  • 3.4. Immune response to parasitic infection
  • 3.5. Mucosal immunity

Chapter 4: Vaccine Technologies

  • 4.1. Conventional vaccines
    • 4.1.1. Live attenuated (modified live) vaccines
    • 4.1.2. Inactivated vaccines
  • 4.2. Molecular approaches to vaccine development
    • 4.2.1. Vector-based veterinary vaccines
    • 4.2.2. Plant based vaccines
    • 4.2.3. DNA Vaccines
    • 4.2.4. Gene deleted vaccines
    • 4.2.5. DIVA vaccines
    • 4.2.6. Virus Like Particles
  • 4.3. Current issues in vaccine stability

Chapter 5: The use of adjuvants and other carriers to enhance the immune response

  • 5.1. Introduction to adjuvants
  • 5.2. Novel approaches to adjuvants
    • 5.2.1. Bacterial ghosts
  • 5.3. Injection site reactions
  • 5.4. Adjuvant delivery systems
    • 5.4.1. Immune stimulating complexes (ISCOM)
    • 5.4.2. Particle based adjuvants
    • 5.4.3. Polymers synthetic and natural
    • 5.4.4. Liposomes
    • 5.4.5. Virosomes
  • 5.5. Cytokines as immunopotentiators
  • 5.6. Nanoparticles
  • 5.7. Other potential adjuvants
  • 5.8. Laser adjuvants

Chapter 6: Poultry vaccines

Chapter 7: Cattle and small ruminant (sheep and goat) vaccines

  • 7.1. Calf enteric disease
  • 7.2. Bovine respiratory disease (BRD)
  • 7.3. Bovine reproductive vaccines
    • 7.3.1. Bovine Viral Diarrhoea Virus (BVDV)
    • 7.3.2. Brucellosis
    • 7.3.3. Neospora caninum
  • 7.4. Bovine tuberculosis
  • 7.5. Mastitis vaccines
  • 7.6. Tick vaccines
  • 7.7. Other parasite vaccines
  • 7.8. Sheep and Goat Vaccines
    • 7.8.1. Introduction
    • 7.8.2. Clostridial disease

Chapter 8: Pig vaccines

  • 8.1. Enteric disease
  • 8.2. Viral vaccines
    • 8.2.1. Swine influenza
    • 8.2.2. Porcine circovirus
    • 8.2.3. Porcine reproductive and respiratory syndrome (PRRSV)
    • 8.2.4. Porcine epidemic diarrhoea (PED)

Chapter 9: Companion animal vaccines

  • 9.1. Dog vaccines
  • 9.2. Cat vaccines
  • 9.3. Equine vaccines

Chapter 10: Vaccines for aquaculture

  • 10.1. Introduction
  • 10.2. Autogenous vaccines for fish
  • 10.3. Viral vaccines in aquaculture
  • 10.4. Bacterial vaccines in aquaculture
  • 10.5. Fish vaccine administration
  • 10.6. Novel delivery systems for fish vaccines

Chapter 11: Routes of vaccine administration

  • 11.1. Needle free vaccination
  • 11.2. Oral/mucosal route
  • 11.3. Oral administration of vaccines in fish

Chapter 12: International Regulation of veterinary vaccines

Chapter 13: Future outlook

References

List of Figures

  • Figure 1: Numbers of dogs in the USA
  • Figure 2: The global veterinary vaccines market
  • Figure 3: Drivers of the veterinary vaccine market
  • Figure 4: Some animal industry statistics published by Vetnosis
  • Figure 5: The global veterinary vaccine market by technology
  • Figure 6: U.S. Animal health market, by product class, 2014-2025 (USD Billion)
  • Figure 7: Sales forecast for veterinary vaccines in India
  • Figure 8: Veterinary vaccine industry in China
  • Figure 9: The Saudi Arabia Animal Vaccines Market, 2014-2022 ($Million)
  • Figure 10: Schematic of the mammalian imune system
  • Figure 11: Illustration of humoral and cell mediated immune pathways (Google)
  • Figure 12: The mucosal immune system (Google)
  • Figure 13: Simplistic overview of the immune system
  • Figure 14: Rinderpest eradication (Arpexas presentation)
  • Figure 15: Scheme of recombinant vaccine development strategies
  • Figure 16: Example of vaccine production from a plant source
  • Figure 17: Representation of a virus like particle.
  • Figure 18: Schematic representation of a liposome
  • Figure 19: Properties of nanoparticles
  • Figure 20: Schematic representation of adjuvant action in stimulating immune responses
  • Figure 21: Mechanism of action of laser adjuvant
  • Figure 22: Common viral pathogens that threaten poultry health.
  • Figure 23: Announcement of the AgResults/GALVmed Brucella vaccine prize
  • Figure 24: The ILRI ECF consortium website

List of Tables

  • Table 1: Landmarks in vaccine technology development over the past 200+ years
  • Table 2: The largest global animal health companies and their revenue (USD billion)
  • Table 3: Characteristics of different categories of veterinary vaccines
  • Table 4: Recombinant veterinary vaccines available in 2017
  • Table 5: Examples of plant-derived immunogenic veterinary viral antigens tested against disease challenge in target animals
  • Table 6: Examples of antigen delivery and immunopotentiator adjuvants
  • Table 7: Bacterial ghosts as candidate vaccines
  • Table 8: Examples of liposomal veterinary vaccines
  • Table 9: Summary descriptions of some commonly used adjuvants in vaccines and research
  • Table 10: Summary characteristics of some bacterial derived adjuvants
  • Table 11: Summary characteristics of non-bacterially derived adjuvants
  • Table 12: Aetiological agents of economically important poultry infectious diseases
  • Table 13: Global systems of poultry production (FAO)
  • Table 14: Some available Brucella vaccine products
  • Table 15: Common sheep disease caused by clostridial organisms
  • Table 16: Vaccines for other enzootic diseases of sheep
  • Table 17: OIE List Diseases of sheep and goats
  • Table 18: Some examples of pig diseases that may be controlled by vaccination
  • Table 19: Examples of multivalent dog vaccines
  • Table 20: Examples of cat multivalent vaccines
  • Table 21: Some fish vaccines marketed globally
  • Table 22: Advantages and disadvantages of vaccine administration via water
  • Table 23: Methods of DNA vaccine delivery
  • Table 24: Vaccines registered by EU centralised procedure 2014-2018
Back to Top